International Journal of Colorectal Disease

, Volume 30, Issue 4, pp 549–557 | Cite as

Coadministration of basic fibroblast growth factor-loaded polycaprolactone beads and autologous myoblasts in a dog model of fecal incontinence

  • Heung-Kwon Oh
  • Hye Seung Lee
  • Jin Ho Lee
  • Se Heang Oh
  • Jae-Young Lim
  • Soyeon Ahn
  • Sung-Bum KangEmail author
Original Article



Basic fibroblastic growth factor (bFGF), a member of the heparin-binding growth factor family, regulates muscle differentiation. We investigated whether coadministration of autologous myoblasts and bFGF-loaded polycaprolactone beads could improve sphincter recovery in a dog model of fecal incontinence (FI).


FI was induced by resecting 25 % of the posterior anal sphincter in ten mongrel dogs. One month later, the dogs were randomized to receive either PKH-26-labeled autologous myoblasts alone (M group, five dogs) or autologous myoblasts and bFGF-loaded polycaprolactone beads (MBG group, five dogs). The outcomes included anal manometry, compound muscle action potentials (CMAPs) of the pudendal nerve, and histology.


The increase in anal contractile pressure over 3 months was significantly greater in the MBG group (from 4.85 to 6.83 mmHg) than that in the M group (from 4.94 to 4.25 mmHg), with a coefficient for the difference in recovery rate of 2.672 (95 % confidence interval [CI] 0.962 to 4.373, p = 0.002). The change in the CMAP amplitude was also significantly greater in the MBG group (from 0.59 to 1.56 mV) than that in the M group (from 0.81 to 0.67 mV) (coefficient 1.114, 95 % CI 0.43 to 1.80, p = 0.001). Labeled cells were detected in 2/5 (40 %) and 5/5 (100 %) dogs in the M and MBG groups, respectively.


Coadministration of bFGF-loaded PCL beads and autologous myoblasts improved the recovery of sphincter function in a dog model of FI and had better outcomes than cell-based therapy alone.


Fecal incontinence Tissue engineering Myoblast Tissue regeneration Growth factor 



The authors thank Myong Hoon Ihn, Jung-Woo Park, Ok-Sun Kim, Sang A Lee, Tae-Ho Kim, Jun-Gu Kang, and Hye-Jin Kim for their assistance and advice.

Conflicts of interest

The authors have no conflicts of interest to report. This work was supported by a grant from the Korean Health Technology R&D Project, The Ministry of Health and Welfare, Republic of Korea (Grant No. A120357).

Research involving human participants and/or snimals (ethical approval)

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the the Animal Care and Use Committee of Seoul National University Bundang Hospital (64-2012-083).

Supplementary material


(MPG 10076 kb)


  1. 1.
    Brown SR, Wadhawan H, Nelson RL (2013) Surgery for faecal incontinence in adults. Cochrane Database Syst Rev 7:CD001757. doi: 10.1002/14651858.CD001757.pub4 PubMedGoogle Scholar
  2. 2.
    Maeda Y, Laurberg S, Norton C (2013) Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2:CD007959. doi: 10.1002/14651858.CD007959.pub3 PubMedGoogle Scholar
  3. 3.
    Kang SB, Lee HN, Lee JY, Park JS, Lee HS, Lee JY (2008) Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of rats. Dis Colon Rectum 51(9):1367–1373. doi: 10.1007/s10350-008-9360-y CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Lorenzi B, Pessina F, Lorenzoni P, Urbani S, Vernillo R, Sgaragli G, Gerli R, Mazzanti B, Bosi A, Saccardi R, Lorenzi M (2008) Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells. Dis Colon Rectum 51(4):411–420. doi: 10.1007/s10350-007-9153-8 CrossRefPubMedGoogle Scholar
  5. 5.
    Kajbafzadeh AM, Elmi A, Talab SS, Esfahani SA, Tourchi A (2010) Functional external anal sphincter reconstruction for treatment of anal incontinence using muscle progenitor cell auto grafting. Dis Colon Rectum 53(10):1415–1421. doi: 10.1007/DCR.0b013e3181e53088 CrossRefPubMedGoogle Scholar
  6. 6.
    Lee WY, Chang YH, Yeh YC, Chen CH, Lin KM, Huang CC, Chang Y, Sung HW (2009) The use of injectable spherically symmetric cell aggregates self-assembled in a thermo-responsive hydrogel for enhanced cell transplantation. Biomaterials 30(29):5505–5513. doi: 10.1016/j.biomaterials.2009.07.006 CrossRefPubMedGoogle Scholar
  7. 7.
    Oh SH, Kim IG, Lee JY, Lee JY, Lee JH (2011) Bioactive porous beads as an injectable urethral bulking agent: their in vitro evaluation on smooth muscle cell differentiation. Tissue Eng Part A 17(5–6):655–664. doi: 10.1089/ten.TEA.2010.0430 CrossRefPubMedGoogle Scholar
  8. 8.
    Basilico C, Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115–165CrossRefPubMedGoogle Scholar
  9. 9.
    Fallon JF, Lopez A, Ros MA, Savage MP, Olwin BB, Simandl BK (1994) FGF-2: apical ectodermal ridge growth signal for chick limb development. Science 264(5155):104–107CrossRefPubMedGoogle Scholar
  10. 10.
    Niswander L, Martin GR (1993) FGF-4 and BMP-2 have opposite effects on limb growth. Nature 361(6407):68–71. doi: 10.1038/361068a0 CrossRefPubMedGoogle Scholar
  11. 11.
    Riley BB, Savage MP, Simandl BK, Olwin BB, Fallon JF (1993) Retroviral expression of FGF-2 (bFGF) affects patterning in chick limb bud. Development 118(1):95–104PubMedGoogle Scholar
  12. 12.
    Kang SB, Lee HS, Lim JY, Oh SH, Kim SJ, Hong SM, Jang JH, Cho JE, Lee SM, Lee JH (2013) Injection of porous polycaprolactone beads containing autologous myoblasts in a dog model of fecal incontinence. J Korean Surg Soc 84(4):216–224. doi: 10.4174/jkss.2013.84.4.216 CrossRefPubMedCentralPubMedGoogle Scholar
  13. 13.
    Choi JS, Lee SJ, Christ GJ, Atala A, Yoo JJ (2008) The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials 29(19):2899–2906. doi: 10.1016/j.biomaterials.2008.03.031 CrossRefPubMedGoogle Scholar
  14. 14.
    Rando TA, Blau HM (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125(6):1275–1287CrossRefPubMedGoogle Scholar
  15. 15.
    Schenk HC, Krampfl K, Baumgartner W, Tipold A (2012) Canine muscle cell culture and consecutive patch-clamp measurements - a new approach to characterize muscular diseases in dogs. BMC Vet Res 8:227. doi: 10.1186/1746-6148-8-227 CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Lim SM, Lee HJ, Oh SH, Kim JM, Lee JH (2009) Novel fabrication of PCL porous beads for use as an injectable cell carrier system. J Biomed Mater Res B Appl Biomater 90(2):521–530. doi: 10.1002/jbm.b.31313 CrossRefPubMedGoogle Scholar
  17. 17.
    Nandivada P, Nagle D (2014) Surgical therapies for fecal incontinence. Curr Opin Gastroenterol 30(1):69–74. doi: 10.1097/MOG.0000000000000029 CrossRefPubMedGoogle Scholar
  18. 18.
    Saihara R, Komuro H, Urita Y, Hagiwara K, Kaneko M (2009) Myoblast transplantation to defecation muscles in a rat model: a possible treatment strategy for fecal incontinence after the repair of imperforate anus. Pediatr Surg Int 25(11):981–986. doi: 10.1007/s00383-009-2454-3 CrossRefPubMedGoogle Scholar
  19. 19.
    Tomita M, Lavik E, Klassen H, Zahir T, Langer R, Young MJ (2005) Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells 23(10):1579–1588. doi: 10.1634/stemcells. 2005-0111 CrossRefPubMedGoogle Scholar
  20. 20.
    Ochi K, Chen G, Ushida T, Gojo S, Segawa K, Tai H, Ueno K, Ohkawa H, Mori T, Yamaguchi A, Toyama Y, Hata J, Umezawa A (2003) Use of isolated mature osteoblasts in abundance acts as desired-shaped bone regeneration in combination with a modified poly-DL-lactic-co-glycolic acid (PLGA)-collagen sponge. J Cell Physiol 194(1):45–53. doi: 10.1002/jcp.10185 CrossRefPubMedGoogle Scholar
  21. 21.
    Oh SH, Lee JH (2013) Hydrophilization of synthetic biodegradable polymer scaffolds for improved cell/tissue compatibility. Biomed Mater 8(1):014101CrossRefPubMedGoogle Scholar
  22. 22.
    Miyasaka EA, Raghavan S, Gilmont RR, Mittal K, Somara S, Bitar KN, Teitelbaum DH (2011) In vivo growth of a bioengineered internal anal sphincter: comparison of growth factors for optimization of growth and survival. Pediatr Surg Int 27(2):137–143. doi: 10.1007/s00383-010-2786-z CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Kudla AJ, John ML, Bowen-Pope DF, Rainish B, Olwin BB (1995) A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways. Mol Cell Biol 15(6):3238–3246PubMedCentralPubMedGoogle Scholar
  24. 24.
    Jump SS, Childs TE, Zwetsloot KA, Booth FW, Lees SJ (2009) Fibroblast growth factor 2-stimulated proliferation is lower in muscle precursor cells from old rats. Exp Physiol 94(6):739–748. doi: 10.1113/expphysiol.2008.046136 CrossRefPubMedGoogle Scholar
  25. 25.
    Anderson JE, Mitchell CM, McGeachie JK, Grounds MD (1995) The time course of basic fibroblast growth factor expression in crush-injured skeletal muscles of SJL/J and BALB/c mice. Exp Cell Res 216(2):325–334. doi: 10.1006/excr.1995.1041 CrossRefPubMedGoogle Scholar
  26. 26.
    Iwata Y, Ozaki N, Hirata H, Sugiura Y, Horii E, Nakao E, Tatebe M, Yazaki N, Hattori T, Majima M, Ishiguro N (2006) Fibroblast growth factor-2 enhances functional recovery of reinnervated muscle. Muscle Nerve 34(5):623–630. doi: 10.1002/mus.20634 CrossRefPubMedGoogle Scholar
  27. 27.
    Lefaucheur JP, Sebille A (1995) Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy. Neurosci Lett 202(1–2):121–124CrossRefPubMedGoogle Scholar
  28. 28.
    Goldfarb M (2005) Fibroblast growth factor homologous factors: evolution, structure, and function. Cytokine Growth Factor Rev 16(2):215–220. doi: 10.1016/j.cytogfr.2005.02.002 CrossRefPubMedCentralPubMedGoogle Scholar
  29. 29.
    Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP, Desnos M, Bruneval P (2003) Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361(9356):491–492. doi: 10.1016/S0140-6736(03)12458-0 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Heung-Kwon Oh
    • 1
  • Hye Seung Lee
    • 2
  • Jin Ho Lee
    • 3
  • Se Heang Oh
    • 4
  • Jae-Young Lim
    • 5
  • Soyeon Ahn
    • 6
  • Sung-Bum Kang
    • 1
    Email author
  1. 1.Department of SurgerySeoul National University College of Medicine, Seoul National University Bundang HospitalSeongnam-siRepublic of Korea
  2. 2.Department of PathologySeoul National University College of Medicine, Seoul National University Bundang HospitalSeongnamRepublic of Korea
  3. 3.Department of Advanced MaterialsHannam UniversityDaejeonRepublic of Korea
  4. 4.Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative MedicineDankook UniversityCheonanRepublic of Korea
  5. 5.Department of RehabilitationSeoul National University College of Medicine, Seoul National University Bundang HospitalSeongnamRepublic of Korea
  6. 6.Division of Statistics, Medical Research Collaborating CenterSeoul National University Bundang HospitalSeongnamRepublic of Korea

Personalised recommendations